A dietitian-led lifestyle modification program helped improve obstructive sleep apnea severity and reduce daytime sleepiness over a 12-month period, Dr. Susanna S. S. Ng reported in Chest.
Dr. Ng and colleagues at the Chinese University of Hong Kong evaluated 104 patients aged 30-80 years with moderate to severe obstructive sleep apnea and a body mass index of at least 25 kg/mg2. All patients had an apnea-hypopnea index (AHI) of greater than 15. Patients were randomized to receive a dietitian-led lifestyle modification program or usual care for 12 months.
Patients in the lifestyle modification program met with a dietitian weekly for the first 4 months, then monthly for the rest of the year. They were advised to cut calories by 10%-20% and eat more protein and fiber, meet at least once with an exercise instructor, and engage in 30-minute aerobic exercise sessions 2-3 times per week. Diet advice was adjusted over time as patients lost weight. Patients in the control arm received lifestyle advice at baseline and at 6 months into the study.
Patients in the lifestyle modification arm lost an average of 1.8 kg while their AHI scores dropped 17% and BMI dropped 6%. Control patients lost 0.6 kg, their AHI scores increased 0.6%, and their BMI was reduced by 2% (Chest 2015;148[5]:1193-1203).
Changes in AHI correlated with changes in weight. AHI, first measured 4 months after the initial intensive diet counseling session, was maintained at 12-month follow-up assessment, with no rebound even after the intensive phase of the dietary intervention ended at 4 months. Secondary endpoint data also were encouraging. Reduction rates in daytime sleepiness and a modest improvement in mental health were seen in patients in the lifestyle modification group.
“This study has shown that a lifestyle modification program was an effective treatment modality in the majority of patients with moderate to severe OSA,” Dr. Ng and colleagues said, adding that “obesity and OSA are strongly associated. These new data provided strong evidence that weight reduction should be the core element in the treatment of OSA.”